JANUS HENDERSON GROUP PLC - Dec 31, 2024 Form SCHEDULE 13G/A Schedule Report for AVADEL PHARMACEUTICALS PLC (AVDL)

Filing Manager
JANUS HENDERSON GROUP PLC
Reporting Manager
JANUS HENDERSON GROUP PLC
Security
AVADEL PHARMACEUTICALS PLC Common Stock
Symbol
AVDL
Shares outstanding
96.4M shares
Disclosed Ownership
14.1M shares
Ownership
14.6%
Form type
SCHEDULE 13G/A
Date filed
2/14/2025, 11:55 AM
Date of event
Dec 31, 2024
SEC
View on sec.gov

Reporting Managers (2)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
JANUS HENDERSON GROUP PLC 14.6% 14.1M 0 14.1M Kristin Mariani Head of North America Compliance, CCO
Janus Henderson Biotech Innovation Master Fund Ltd 5.4% 5.2M 0 5.2M Kristin Mariani Head of North America Compliance, CCO